AI assistant
Sending…
ALICO, INC. — Director's Dealing 2004
Jun 8, 2004
33480_dirs_2004-06-08_b17d02f7-da9e-44b6-a962-3f3ebe167892.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ALICO INC (alco)
CIK: 0000003545
Period of Report: 2004-06-04
Reporting Person: GRIFFIN BEN HILL III (Past Chairman of the Board & C)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-06-04 | Alico, Inc., Common Stock, Par Value $1.00 | M | 2146 | $15.68 | Acquired | 2146 | Direct |
| 2004-06-04 | Alico, Inc., Common Stock, Par Value $1.00 | S | 2146 | $35.0162 | Disposed | 0 | Direct |
| 2004-06-07 | Alico, Inc., Common Stock, Par Value $1.00 | M | 1015 | $15.68 | Acquired | 1015 | Direct |
| 2004-06-07 | Alico, Inc., Common Stock, Par Value $1.00 | S | 518 | $35.2257 | Disposed | 497 | Direct |
| 2004-06-07 | Alico, Inc., Common Stock, Par Value $1.00 | S | 497 | $35.11 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-06-04 | Option for Common Stock | $15.68 | M | 2146 | Acquired | 2013-09-09 | Common Stock (2146) | Direct |
| 2004-06-04 | Option for Common Stock | $15.68 | S | 2146 | Disposed | 2013-09-09 | Common Stock (2146) | Direct |
| 2004-06-07 | Option for Common Stock | $15.68 | M | 1015 | Acquired | 2013-09-09 | Common Stock (1015) | Direct |
| 2004-06-07 | Option for Common Stock | $15.68 | S | 1015 | Disposed | 2013-09-09 | Common Stock (1015) | Direct |
More from ALICO, INC.
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 2
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Feb 4
Interim / Quarterly Report
2026
Feb 4
Proxy Solicitation & Information Statement
2026
Jan 14
Proxy Solicitation & Information Statement
2026
Jan 14
Director's Dealing
2026
Jan 5